Bausch Health Companies Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

BAUSCH HEALTH COMPANIES INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box)

Notice of the 2026

Annual Meeting of

Bausch Health

Companies Inc.

Date and Time

Tuesday, May 19, 2026

9:00 a.m.

Eastern Daylight Time

Place

Meeting via the Internet. Please visit:

www.virtualshareholder

meeting.com/BHC2026

YOUR VOTE IS IMPORTANT

Whether or not you plan to attend the meeting, we encourage you to vote as soon as possible. For specific instructions on how to vote your shares, please refer to the instructions on the Notice of Internet Availability of Proxy Materials you received in the mail, the section titled “Questions About Voting” on page 83 of this proxy statement, or if you requested to receive printed proxy materials, your enclosed proxy card.

TO OUR SHAREHOLDERS

Purposes of the Annual Meeting

Elect ten directors to serve on the Board of Directors for a one-year term expiring at the 2027 Annual Meeting of Shareholders.

Approve, in an advisory vote, the compensation of our named executive officers in 2025.

Appoint PricewaterhouseCoopers LLP (“PwC”) to serve as the Company’s auditor until the close of the 2027 Annual Meeting of Shareholders and to authorize the Board to fix the auditor’s remuneration.

Receive the audited consolidated financial statements of the Company for the year ended December 31, 2025, and the auditor’s report thereon.

Transact such other business as may properly come before the Meeting or any adjournments or postponements thereof.

Holders of record of the Company’s Common Shares as of the close of business on March 20, 2026 are entitled to notice of, and to vote at, the Annual Meeting. This proxy statement is first being mailed to our shareholders on or about April 8, 2026.

IMPORTANT NOTICE regarding the Availability of Proxy Materials for the Annual Meeting of shareholders to be held on May 19, 2026: This proxy statement and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, are available free of charge on the Company’s website at bauschhealth.com.

By Order of the Board of Directors,

Seana Carson

Executive Vice President, General Counsel

April 8, 2026

2150 Saint Elzéar Blvd. West

Laval, Québec H7L 4A8

MANAGEMENT PROXY CIRCULAR AND PROXY STATEMENT

This Management Proxy Circular and Proxy Statement (“Proxy Statement”) contains information about the 2026 Annual Meeting of Shareholders of Bausch Health Companies Inc., which will be conducted in an exclusively virtual format via a live internet webcast atwww.virtualshareholdermeeting.com/BHC2026 at 9:00 a.m., Eastern Daylight Time, on Tuesday, May 19, 2026, and at any adjournments or postponements thereof (the “Annual Meeting” or “Meeting”), for the purposes set forth in this Proxy Statement and in the accompanying Notice of Annual Meeting of Shareholders. In this document, the words “Bausch Health,” “BHC,” “we,” “our,” “ours” “us” and similar terms refer only to Bausch Health Companies Inc. and not to any other person or entity. Unless otherwise indicated, the statistical and financial data contained in this Proxy Statement are as of March 20, 2026.

We are providing you with this Proxy Statement and related materials in connection with the solicitation of proxies by our management. See the section titled “Voting & Other Information — Proxy Solicitation” on page 81 for additional information.

We are providing access to our proxy materials, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, in a fast and efficient manner via the internet (including through the use of notice-and-access procedures under Canadian securities laws). On April 8, 2026, we will begin mailing the proxy materials to all shareholders as of the record date of March 20, 2026 and post our proxy materials on the website referenced in the Notice (www.proxyvote.com).

All properly executed written proxies, and all properly completed proxies submitted via the internet or by telephone or mail, which are delivered pursuant to, and which appoint Thomas J. Appio and Seana Carson, or each of them, each with the power to appoint his or her substitute, as proxyholders in accordance with, this solicitation will be voted at the Annual Meeting in accordance with the directions given in the proxy, unless the proxy is revoked prior to completion of voting at the Annual Meeting.

This Proxy Statement and the Annual Report are available at: www.proxyvote.com.

This Proxy Statement contains information regarding, among other things:

Whether or not you plan to attend the Meeting, please promptly provide your voting instructions. Your promptness in voting will assist in the expeditious and orderly processing of the proxies and in ensuring that a quorum is present at the Meeting. If you vote your proxy or follow the instructions for voting from the voting instruction form, you may nevertheless attend, and vote your Common Shares during, the live webcast of the Meeting by using the 16-digit control number on the Notice, proxy card or voting instruction form. If you want to revoke your instructions at a later time prior to the vote for any reason, you may do so in the manner described in this Proxy Statement.

Summary of Board Recommendations

The Board of Directors (the “Board”) unanimously recommends that you vote:

In addition, you may be asked to vote in respect of any other matters that may properly be brought before the Meeting. As of the date of this Proxy Statement, the Board is not aware of any such other matters.

Cautionary Note Regarding Forward-Looking Statements

This Proxy Statement contains forward-looking statements within the meaning of applicable securities laws (collectively, “forward-looking statements”), which may generally be identified by the use of the words “anticipates,” “hopes,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “believes,” “estimates,” “potential,” “target,” or “continue” and variations or similar expressions. These statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. These risks and assumptions are described under “Forward-Looking Statements” and Item 1A. “Risk Factors” in the Company’s Form 10-K for the year ended December 31, 2025, and in the Company’s other filings with the SEC and the Canadian Securities Administrators, which are incorporated herein by reference. These factors are not exhaustive, and undue reliance should not be placed on forward-looking statements. Forward-looking statements speak only as of the date of this Proxy Statement. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.